INVESTORS
SantoSolve is privatly held, and investors in the company includes some of the leading life science venture funds in Scandinavia. The company completed a Series D financing round in the Fall 2009, totalling approx USDm 5. Participants in the round included both existing and new investors.
The three largest shareholders in SantoSolve are:
Teknoinvest
Teknoinvest is a premier Scandinavian venture capital company headquartered in Norway. It invests in areas of emerging technologies within the IT and Life Sciences sectors in Scandinavia and the US. Teknoinvest was established as the first venture capital investment company in Norway in 1984, and have an extensive network throughout Scandinavia and the US which has enabled investments in several successful companies.
For more information: www.teknoinvest.com
InnovationsKapital
InnovationsKapital is a leading independent, early stage venture capital firm for innovative growth companies in the Nordic region.
Years of experience and a strong network within academia and industry has enabled investments in successful science and research based companies.
Since 1994, InnovationsKapital have made over 55 investments in the life sciences and technology sectors.
For more information: www.innovationskapital.se
Investinor
Investinor AS invests in Norwegian based, high potential companies that are internationally oriented and in the phases ranging from early growth to expansion.
The company has BNOK 2,2 under management and focus on companies within the energy, cleantech, maritime, marine and travel sectors.
Investinor AS has a co-investment strategy and contributes up to 50% in each round, and can take up to 49% equity ownership of a portfolio company.
Investinor is fully owned by Innovation Norway , which is owned by the Norwegian Ministry of Trade and Industry.
For more information: www.investinor.no
In addition to the above investors, SantoSolve has attracted investments from a number of smaller institutional investors.
|
